Quick Answer
Twist Bioscience Corp reported R&D Expense of $80.28 million for fiscal year 2025.
Twist Bioscience Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $80.28M | -11.6% |
| 2024 | $90.85M | -15.0% |
| 2023 | $106.89M | -11.1% |
| 2022 | $120.31M | +74.2% |
| 2021 | $69.07M | +60.6% |
| 2020 | $43.01M | +20.5% |
| 2019 | $35.68M | +75.4% |
| 2018 | $20.35M | +6.1% |
| 2017 | $19.17M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $17.13M | -19.6% | -5.1% |
| June 30, 2025 | $18.05M | -19.7% | -24.5% |
| March 31, 2025 | $23.92M | -1.0% | +12.2% |
| December 31, 2024 | $21.31M | -7.8% | -5.2% |
| June 30, 2024 | $22.47M | -8.4% | -7.0% |
| March 31, 2024 | $24.15M | -11.8% | +4.5% |
| December 31, 2023 | $23.10M | -26.1% | -5.8% |
| June 30, 2023 | $24.53M | -33.4% | -10.4% |
- Twist Bioscience Corp showed a decrease of -11.6% in R&D Expense compared to the prior fiscal year.
- Over the 2017–2025 period, Twist Bioscience Corp’s r&d expense has grown by 318.8% (from $19.17 million to $80.28 million).
- The most recent figure is from Twist Bioscience Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: